https://www.selleckchem.com/pr....oducts/PIK-75-Hydroc
Analyses of study completer data for 28 participants suggested comparable efficacy of both medications; however, lamotrigine had a distinctly lower rate of severe side effects across the study. We calculated that if study trends on outcome measures were valid, then an extremely large sample would be required to demonstrate superiority of either drug, thus making it unlikely that any such adequately powered study will be mounted in the future. The small sample size limits any definitive conclusions, but our data suggest that
Like
Comment
Share
